These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dermacase. Can you identify this condition? Hidradenitis suppurativa. Li K; Barankin B Can Fam Physician; 2011 Sep; 57(9):1023. PubMed ID: 21918148 [No Abstract] [Full Text] [Related]
23. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group. Horváth B; Janse IC; Blok JL; Driessen RJ; Boer J; Mekkes JR; Prens EP; van der Zee HH Acta Derm Venereol; 2017 Mar; 97(3):412-413. PubMed ID: 27535129 [No Abstract] [Full Text] [Related]
24. Surgery is an essential aspect of managing patients with hidradenitis suppurativa. Melendez Gonzalez MDM; Sayed CJ J Am Acad Dermatol; 2020 Sep; 83(3):979-980. PubMed ID: 32171813 [No Abstract] [Full Text] [Related]
25. Hidradenitis suppurativa: a disease of apocrine gland physiology. Lasko LA; Post C; Kathju S JAAPA; 2008 Nov; 21(11):23-5. PubMed ID: 19105543 [No Abstract] [Full Text] [Related]
26. [Management of hidradenitis suppurativa]. Antoine B Rev Prat; 2024 May; 74(5):471-476. PubMed ID: 38833220 [No Abstract] [Full Text] [Related]
27. Advances Toward the Clinical Translation of Hidradenitis Suppurativa Genetic Studies. Khan A; Petukhova L JAMA Dermatol; 2023 Sep; 159(9):913-915. PubMed ID: 37494029 [No Abstract] [Full Text] [Related]
29. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. Gold DA; Reeder VJ; Mahan MG; Hamzavi IH J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875 [TBL] [Abstract][Full Text] [Related]
30. Barriers to Dermatologic Care and Use of Internet Sources in Hidradenitis Suppurativa. Poondru S; Scott K; Riley JM J Drugs Dermatol; 2023 Jul; 22(7):710-711. PubMed ID: 37410039 [TBL] [Abstract][Full Text] [Related]
31. A practical guide to hidradenitis suppurativa. Marti-Amarista C; Rali M J Fam Pract; 2022 Dec; 71(10):E1-E12. PubMed ID: 36735944 [TBL] [Abstract][Full Text] [Related]
32. The Critical Need for Reliable and Clinically Meaningful Outcome Measures for Hidradenitis Suppurativa. Naik HB JAMA Dermatol; 2023 Jun; 159(6):581-583. PubMed ID: 37099321 [No Abstract] [Full Text] [Related]
33. Hidradenitis suppurativa: a clinician's tool for early diagnosis and treatment. Beshara MA Nurse Pract; 2010 May; 35(5):24-8; quiz 28-9. PubMed ID: 20395763 [No Abstract] [Full Text] [Related]
35. Medical therapy is the optimal treatment for hidradenitis suppurativa. Daveluy S J Am Acad Dermatol; 2020 Sep; 83(3):977-978. PubMed ID: 32171810 [No Abstract] [Full Text] [Related]
38. Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? Ruggiero A; Marasca C; Fabbrocini G; Villani A; Martora F J Cosmet Dermatol; 2023 Feb; 22(2):677-678. PubMed ID: 35951634 [No Abstract] [Full Text] [Related]
39. Management of mild hidradenitis suppurativa: our greatest challenge yet. van der Zee HH; van de Bunte M; van Straalen KR Br J Dermatol; 2022 Feb; 186(2):355-356. PubMed ID: 34608630 [No Abstract] [Full Text] [Related]
40. Hidradenitis Suppurativa: The Disease Which Stimulates Researchers and Clinicians. Szepietowski JC; Matusiak Ł Dermatology; 2020; 236(1):5-7. PubMed ID: 31955165 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]